Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Lin

Showing results (231-240 of 328) with videos related to

Pageof 33
Sort By:
Lung Cancer (Amsterdam, Netherlands)|March 13, 2026
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world studySteven H Lin, Doreen A Kahangire, Saurabh P Nagar, et al.
Acta Oncologica (Stockholm, Sweden)|September 7, 2012
Metformin use and improved response to therapy in esophageal adenocarcinomaHeath D Skinner, Matthew R McCurdy, Alfredo E Echeverria, et al.
Cancers|April 13, 2023
Independent Reproduction of the FLASH Effect on the Gastrointestinal Tract: A Multi-Institutional Comparative StudyAnet Valdés Zayas, Neeraj Kumari, Kevin Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2020
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear AnalysisShane Mesko, Matthew S Ning, David Lakomy, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2017
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly PatientsScott C Lester, Steven H Lin, Michael Chuong, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2012
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancerYuki Hayashi, Lianchun Xiao, Akihiro Suzuki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2018
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung CancerChonnipa Nantavithya, Daniel R Gomez, Xiong Wei, et al.
Annals of Surgery|June 20, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal AdenocarcinomaMian Xi, Christopher L Hallemeier, Kenneth W Merrell, et al.
The Lancet. Oncology|October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
Arxiv|June 3, 2024
On the acceptance, commissioning, and quality assurance of electron FLASH unitsAllison Palmiero, Kevin Liu, Julie Colnot, et al.
Pageof 33

Showing results (231-240 of 328) with videos related to

Sort By:
Pageof 33
Lung Cancer (Amsterdam, Netherlands)|March 13, 2026
EGFR mutation status, treatment patterns, and outcomes in resectable early-stage non-small cell lung cancer prior to adjuvant EGFR-TKI approval: An international real-world studySteven H Lin, Doreen A Kahangire, Saurabh P Nagar, et al.
Acta Oncologica (Stockholm, Sweden)|September 7, 2012
Metformin use and improved response to therapy in esophageal adenocarcinomaHeath D Skinner, Matthew R McCurdy, Alfredo E Echeverria, et al.
Cancers|April 13, 2023
Independent Reproduction of the FLASH Effect on the Gastrointestinal Tract: A Multi-Institutional Comparative StudyAnet Valdés Zayas, Neeraj Kumari, Kevin Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2020
Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear AnalysisShane Mesko, Matthew S Ning, David Lakomy, et al.
International Journal of Radiation Oncology, Biology, Physics|May 7, 2017
A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly PatientsScott C Lester, Steven H Lin, Michael Chuong, et al.
European Journal of Cancer (Oxford, England : 1990)|August 3, 2012
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancerYuki Hayashi, Lianchun Xiao, Akihiro Suzuki, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2018
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung CancerChonnipa Nantavithya, Daniel R Gomez, Xiong Wei, et al.
Annals of Surgery|June 20, 2017
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal AdenocarcinomaMian Xi, Christopher L Hallemeier, Kenneth W Merrell, et al.
The Lancet. Oncology|October 3, 2024
Challenges and opportunities for early phase clinical trials of novel drug-radiotherapy combinations: recommendations from NRG Oncology, the American Society for Radiation Oncology (ASTRO), the American College of Radiology (ACR), the Sarah Cannon Research Institute, and the American College of Radiation Oncology (ACRO)Zachary S Zumsteg, Siddharth Sheth, Salma K Jabbour, et al.
Arxiv|June 3, 2024
On the acceptance, commissioning, and quality assurance of electron FLASH unitsAllison Palmiero, Kevin Liu, Julie Colnot, et al.
Pageof 33